PleoPharma Awarded $6.5 Million NIDA Grant to Support Phase 3 Trial of PP-01 for Cannabis Withdrawal in Patients with Cannabis Use Disorder
NIH/NIDA funding will support a pivotal clinical program for an investigational treatment for adults with cannabis use disorder
PHOENIXVILLE, Pa., Aug. 20, 2026 /PRNewswire/ — PleoPharma, Inc., a c…